Eggert A - Search Results

1

MYCN regulates oncogenic MicroRNAs in neuroblastoma.

Schulte JH, Horn S, Otto T, Samans B, Heukamp LC, Eilers UC, Krause M, Astrahantseff K, Klein-Hitpass L, Buettner R, Schramm A, Christiansen H, Eilers M, Eggert A, Berwanger B. Schulte JH, et al. Among authors: eggert a. Int J Cancer. 2008 Feb 1;122(3):699-704. doi: 10.1002/ijc.23153. Int J Cancer. 2008. PMID: 17943719 Free article.

2

Prognostic and biological role of neurotrophin-receptor TrkA and TrkB in neuroblastoma.

Eggert A, Ikegaki N, Liu XG, Brodeur GM. Eggert A, et al. Klin Padiatr. 2000 Jul-Aug;212(4):200-5. doi: 10.1055/s-2000-9677. Klin Padiatr. 2000. PMID: 10994551

3

Different effects of TrkA expression in neuroblastoma cell lines with or without MYCN amplification.

Eggert A, Ho R, Ikegaki N, Liu XG, Brodeur GM. Eggert A, et al. Med Pediatr Oncol. 2000 Dec;35(6):623-7. doi: 10.1002/1096-911x(20001201)35:6<623::aid-mpo29>3.0.co;2-h. Med Pediatr Oncol. 2000. PMID: 11107132

4

Resistance to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in neuroblastoma cells correlates with a loss of caspase-8 expression.

Eggert A, Grotzer MA, Zuzak TJ, Wiewrodt BR, Ho R, Ikegaki N, Brodeur GM. Eggert A, et al. Cancer Res. 2001 Feb 15;61(4):1314-9. Cancer Res. 2001. PMID: 11245427

5

Expression of the neurotrophin receptor TrkA down-regulates expression and function of angiogenic stimulators in SH-SY5Y neuroblastoma cells.

Eggert A, Grotzer MA, Ikegaki N, Liu XG, Evans AE, Brodeur GM. Eggert A, et al. Cancer Res. 2002 Mar 15;62(6):1802-8. Cancer Res. 2002. PMID: 11912158

6

Proteomics: techniques and applications in cancer research.

Schramm A, Apostolov O, Sitek B, Pfeiffer K, Stühler K, Meyer HE, Havers W, Eggert A. Schramm A, et al. Among authors: eggert a. Klin Padiatr. 2003 Nov-Dec;215(6):293-7. doi: 10.1055/s-2003-45502. Klin Padiatr. 2003. PMID: 14677091

7

Microarray-analysis: a new approach to study the molecular mechanisms of thermo-chemotherapy.

Schulte JH, Schramm A, Pressel T, Klein-Hitpass L, Kremens B, Eils J, Havers W, Eggert A. Schulte JH, et al. Among authors: eggert a. Klin Padiatr. 2003 Nov-Dec;215(6):298-302. doi: 10.1055/s-2003-45501. Klin Padiatr. 2003. PMID: 14677092

8

Microarray analysis reveals differential gene expression patterns and regulation of single target genes contributing to the opposing phenotype of TrkA- and TrkB-expressing neuroblastomas.

Schulte JH, Schramm A, Klein-Hitpass L, Klenk M, Wessels H, Hauffa BP, Eils J, Eils R, Brodeur GM, Schweigerer L, Havers W, Eggert A. Schulte JH, et al. Among authors: eggert a. Oncogene. 2005 Jan 6;24(1):165-77. doi: 10.1038/sj.onc.1208000. Oncogene. 2005. PMID: 15637590

9

Identification of dynamic proteome changes upon ligand activation of Trk-receptors using two-dimensional fluorescence difference gel electrophoresis and mass spectrometry.

Sitek B, Apostolov O, Stühler K, Pfeiffer K, Meyer HE, Eggert A, Schramm A. Sitek B, et al. Among authors: eggert a. Mol Cell Proteomics. 2005 Mar;4(3):291-9. doi: 10.1074/mcp.M400188-MCP200. Epub 2005 Jan 15. Mol Cell Proteomics. 2005. PMID: 15654083 Free article.

10

Biological effects of TrkA and TrkB receptor signaling in neuroblastoma.

Schramm A, Schulte JH, Astrahantseff K, Apostolov O, Limpt Vv, Sieverts H, Kuhfittig-Kulle S, Pfeiffer P, Versteeg R, Eggert A. Schramm A, et al. Among authors: eggert a. Cancer Lett. 2005 Oct 18;228(1-2):143-53. doi: 10.1016/j.canlet.2005.02.051. Cancer Lett. 2005. PMID: 15921851 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

417 results

Search Page